Canopy Growth (CGC) Interest Coverage Ratio (2019 - 2026)
Canopy Growth (CGC) posted Interest Coverage Ratio of 2.55 for Q4 2025, down 32.61% sequentially from 1.92 in Q3 2025, and down 79.13% YoY from 12.2 in Q4 2024.
Canopy Growth (CGC) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Canopy Growth has reported Interest Coverage Ratio for 7 years, with the latest figure at 2.55 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 79.13% year-over-year to 2.55 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.11 (up 13.71% YoY) and the FY2026 annual result came in at 0.11, down 34.87% from the prior year.
- Interest Coverage Ratio slipped to 2.55 in Q4 2025 per CGC's latest filing, from 1.92 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.26 in Q3 2023 and troughed at 68.49 in Q2 2022.
- A 5-year average of 8.49 and a median of 3.39 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio surged 98.94% in 2021, then slumped 796.25% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 5.68 in 2021, then jumped by 40.38% to 3.39 in 2022, then grew by 27.65% to 2.45 in 2023, then jumped by 42.0% to 1.42 in 2024, then sank by 79.13% to 2.55 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.55, 1.92, and 2.32 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 442.95 Mn | 195.94 Mn | 16.08 Mn | -1.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.74 |
| Dec 31, 2025 | -2.55 |
| Sep 30, 2025 | -1.92 |
| Jun 30, 2025 | -2.32 |
| Dec 31, 2024 | -1.42 |
| Sep 30, 2024 | -2.16 |
| Jun 30, 2024 | -1.38 |
| Mar 31, 2024 | -4.23 |
| Dec 31, 2023 | -2.45 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -1.70 |
| Mar 31, 2023 | -13.23 |
| Dec 31, 2022 | -3.39 |
| Sep 30, 2022 | -4.90 |
| Jun 30, 2022 | -68.49 |
| Mar 31, 2022 | -11.19 |
| Dec 31, 2021 | -5.68 |
| Sep 30, 2021 | -8.08 |
| Jun 30, 2021 | -7.64 |
| Mar 31, 2021 | -18.27 |